Literature DB >> 29922968

Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.

Mostafa A Sayed Ali1, Eman Mohamed Hussein Khedr2, Fatma Alzahraa Hassan Ahmed2, Nada Nasr Eldin Mohamed2.   

Abstract

Background Drug-related problems (DRPs) are common in hospitalized patients with neurological diseases. Clinical pharmacy services could minimize drug-related harm and improve patient care. Objective To identify common DRPs in neurology and document clinical pharmacists' medication-related interventions. Setting The wards and intensive care unit of the Department of Neurology at Assiut University Hospital. Method Prospective study of clinical pharmacists' interventions during the routine care work of reviewing patients medical charts over a period of 6 months from January to June 2017. Main outcome measure The frequency and severity of DRPs and clinical pharmacists' recommendations. Results Out of 1421 reviewed medications charts, a total of 414 DRPs were detected for 285 admitted patients. The most common DRPs were drug selection problems (36.7%) and dosing errors (27.5%). The majority of DRPs (71.7%) were categorized as causing no patient harm. Clinical pharmacists provided recommendations for the detected problems that ranged from drug monitoring to stop and starting new medicines. About 90% of pharmacists' interventions were accepted by physicians. Poisson regression of factors that may influence the frequency of DRPs revealed significant associations of patient age (p = 0.03) and the number of comorbid diseases (p = 0.01). Conclusions Prescribing errors in neurology inpatient are likely to occur. Clinical pharmacists' interventions assisted in early detection of drug problems and prevention of the consequent patient harms.

Entities:  

Keywords:  Clinical pharmacists; Drug-related problems; Egypt; Hospitalized patients; Neurology; Patient harm

Mesh:

Year:  2018        PMID: 29922968     DOI: 10.1007/s11096-018-0658-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  13 in total

1.  Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatients.

Authors:  Anne B Taegtmeyer; Ivanka Curkovic; Natascia Corti; Christoph Rosen; Marco Egbring; Stefan Russmann; Andreas R Gantenbein; Michael Weller; Gerd A Kullak-Ublick
Journal:  Swiss Med Wkly       Date:  2012-07-09       Impact factor: 2.193

Review 2.  Clinical pharmacists and inpatient medical care: a systematic review.

Authors:  Peter J Kaboli; Angela B Hoth; Brad J McClimon; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2006-05-08

3.  Analysis of drug-related problems in three departments of a German University hospital.

Authors:  Rebekka Lenssen; Axel Heidenreich; Jörg B Schulz; Christian Trautwein; Christina Fitzner; Ulrich Jaehde; Albrecht Eisert
Journal:  Int J Clin Pharm       Date:  2015-10-28

4.  Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial.

Authors:  Lina Bladh; Ellinor Ottosson; John Karlsson; Lars Klintberg; Susanna M Wallerstedt
Journal:  BMJ Qual Saf       Date:  2011-01-05       Impact factor: 7.035

5.  An evaluation of clinical pharmacist service on a neurology care unit.

Authors:  Zhan-Miao Yi; Shu-Sen Sun; Xiao-Xiao Li; Ming Lu; Suo-Di Zhai
Journal:  Int J Clin Pharm       Date:  2015-12-10

6.  Drug interaction and pharmacist.

Authors:  Ja Ansari
Journal:  J Young Pharm       Date:  2010-07

Review 7.  Neurologic Complications in the Intensive Care Unit.

Authors:  Clio Rubinos; Sean Ruland
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 8.  Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review.

Authors:  Penny J Lewis; Tim Dornan; David Taylor; Mary P Tully; Val Wass; Darren M Ashcroft
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 9.  Measuring the severity of prescribing errors: a systematic review.

Authors:  Sara Garfield; Matthew Reynolds; Liesbeth Dermont; Bryony Dean Franklin
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

10.  Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England.

Authors:  Kay Seden; Jamie J Kirkham; Tom Kennedy; Michael Lloyd; Sally James; Aine McManus; Andrew Ritchings; Jennifer Simpson; Dave Thornton; Andrea Gill; Carolyn Coleman; Bethan Thorpe; Saye H Khoo
Journal:  BMJ Open       Date:  2013-01-09       Impact factor: 2.692

View more
  7 in total

1.  Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study.

Authors:  Gosaye Mekonen Tefera; Ameha Zewudie Zeleke; Yitagesu Mamo Jima; Tsegaye Melaku Kebede
Journal:  Drug Healthc Patient Saf       Date:  2020-05-04

2.  Development of Key Performance Indicators for Capturing Impact of Pharmaceutical Care in Palestinian Integrative Healthcare Facilities: A Delphi Consensus Study.

Authors:  Ramzi Shawahna
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-25       Impact factor: 2.629

3.  Quality Indicators of Pharmaceutical Care in Palestinian Integrative Healthcare Facilities: Findings of a Qualitative Study among Stakeholders.

Authors:  Ramzi Shawahna
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

4.  Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.

Authors:  João Paulo Vilela Rodrigues; Fabiana Angelo Marques; Ana Maria Rosa Freato Gonçalves; Marília Silveira de Almeida Campos; Tiago Marques Dos Reis; Manuela Roque Siani Morelo; Andrea Fontoura; Beatriz Maria Pereira Girolineto; Helen Palmira Miranda de Camargo Souza; Maurílio de Souza Cazarim; Lauro César da Silva Maduro; Leonardo Régis Leira Pereira
Journal:  PLoS One       Date:  2019-01-18       Impact factor: 3.240

5.  Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions.

Authors:  Noe Garin; Nuria Sole; Beatriz Lucas; Laia Matas; Desiree Moras; Ana Rodrigo-Troyano; Laura Gras-Martin; Nuria Fonts
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

6.  Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China.

Authors:  Pengpeng Liu; Guangyao Li; Mei Han; Chao Zhang
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-26       Impact factor: 2.483

7.  Evaluation of the effect of pharmaceutical care during inpatient treatment in a department of neurology: A retrospective study.

Authors:  Wen Ji; Ruowei Xiao; Bei Wu; Sheng Han; Jinju Duan; Zhiqiang Meng; Mingxu Yang; Chen Wang
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.